FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pantoprazole Sodium for Injection
Status: Currently in Shortage
»Date first posted: 05/28/2019
»Therapeutic Categories: Gastroenterology

Expand all

Aurobindo Pharma (Revised 04/16/2021)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 55150-202-10) Available Check wholesalers for inventory Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2021)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0143-9284-10) This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing in the April - May 2021 timeframe. Product will be made available as it is released. Demand increase for the drug

Pfizer Pharmaceuticals (Revised 04/23/2021)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0008-0923-55) Limited Supply Available. Next Delivery: April 2021; Estimated Recovery: September 2021 Other
40 mg, 25 vials (NDC 0008-0923-60) Next Delivery: April 2021; Estimated Recovery: September 2021 Other
40 mg, 10 vials (NDC 0008-2001-10; Amerinet) Limited Supply Available. Next Delivery and Estimated Recovery: May 2021 Other
40 mg, 25 vials (NDC 0008-2001-25; Amerinet) Limited Supply Available. Next Delivery: April 2021; Estimated Recovery: August 2021 Other
40 mg, 10 vials (NDC 0008-4001-10; PremierPro) Limited Supply Available. Next Delivery: April 2021; Estimated Recovery: September 2021 Other
40 mg, 25 vials (NDC 0008-4001-25; PremierPro) Limited Supply Available. Next Delivery: April 2021; Estimated Recovery: September 2021 Other

Sandoz (Reverified 05/05/2021)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0781-3232-95) Intermittent/Limited supply until April 2021 Demand increase for the drug

Sun Pharmaceutical Industries Inc. (Revised 01/29/2021)

Company Contact Information:
800-818-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 62756-129-44) At present out of Stock, next shipment estimated to arrive in March 2021 Temporary production Issue which is being resolved. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English